Cite

HARVARD Citation

    Arias, L. et al. (2008). Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. British journal of ophthalmology. 92 (8), pp. 1035-1039. [Online]. 
  
Back to record